TrialNutrients2022

Dose-Escalating (50-500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial.

Jordy P W Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.